QUANTERIX CORPORATION

(QTRX)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 24-06-2022
18.79 USD   -3.69%
06/06Quanterix kondigt de benoeming aan van Karen A. Flynn in de Raad van Bestuur
CI
19/05Quanterix Corporation kondigt het ontslag aan van Dawn Mattoon als Senior Vice President, Diagnostics, met ingang van 10 juli 2022
CI
11/05QUANTERIX CORPORATION : Goldman Sachs handhaaft het Neutraal advies
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Communiqués de presse de la société QUANTERIX CORPORATION
24/06QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
09/06Quanterix to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
BU
06/06QUANTERIX : Announces Appointment of Karen A. Flynn to Board of Directors - Form 8-K
PU
06/06QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
06/06Quanterix Announces Appointment of Karen A. Flynn to Board of Directors
BU
19/05QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
10/05QUANTERIX CORP Management's Discussion and Analysis of Financial Condition and Results..
AQ
10/05Quanterix Corporation Releases Operating Results for First Quarter 2022
BU
03/05Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022
BU
28/04QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
22/04Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multip..
BU
04/04Quanterix' Simoa® Technology Powers Large, International Comprehensive Reference Range ..
BU
29/03Quanterix Receives Funding from the Alzheimer's Drug Discovery Foundation to Accelerate..
BU
09/03Quanterix to Participate in Barclays Global Healthcare Conference
BU
03/03Quanterix to Participate in The Cowen 42nd Annual Health Care Conference On March 9
BU
01/03QUANTERIX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
01/03QUANTERIX : Releases Operating Results for Fourth Quarter and Full Year 2021 - Form 8-K
PU
01/03QUANTERIX CORP : Results of Operations and Financial Condition, Change in Directors or Pri..
AQ
01/03Quanterix Announces Executive Leadership Succession Plan
BU
01/03Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021
BU
01/03Quanterix Announces New Agreements with Lilly to Advance Alzheimer's Disease Diagnosis ..
BU
28/02Quanterix Corporation Garners Five Best Places to Work Awards from Comparably
BU
23/02Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on..
BU
09/02Quanterix to Participate in the SVB Leerink Global Healthcare Conference
BU
08/02UK Dementia Research Institute Biomarker Factory Powers Alzheimer's Disease Breakthroug..
BU
31/01QUANTERIX CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhi..
AQ
26/01Quanterix' Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multi..
BU
13/01QUANTERIX : Provides Operational and Preliminary Financial Highlights - Form 8-K
PU
13/01Quanterix Provides Operational and Preliminary Financial Highlights
BU
06/01Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference
BU
2021Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte..
BU
2021Quanterix' Simoa® Technology Powers Advances in Alzheimer's Disease Research Presented ..
BU
2021QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
2021Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digi..
BU
2021Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and N..
BU
2021Quanterix Corporation Releases Operating Results for Third Quarter of 2021 - Form 8-K
PU
2021QUANTERIX CORP Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021Quanterix Corporation Releases Operating Results for Third Quarter of 2021
BU
2021Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
BU
2021QUANTERIX : Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181..
BU
2021QUANTERIX : Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
BU
2021QUANTERIX : Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
BU
2021QUANTERIX TO HOST WEBINAR WITH LEADI : “COVID-19 Testing in a Residential University..
BU
2021QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
2021CASSAVA SCIENCES : Releases Statement Regarding Plasma p-tau Analysis from a Previously Di..
AQ
2021QUANTERIX : Releases Statement
BU
2021QUANTERIX : to Participate in the Canaccord Genuity 41st Annual Growth Conference
BU
2021QUANTERIX : Simoa® Technology Powers Breakthrough Alzheimer's Disease Research Presented b..
BU
2021QUANTERIX : Management's Discussion and Analysis of Financial Condition and Results of Ope..
AQ
2021QUANTERIX CORPORATION : Releases Operating Results for Second Quarter of 2021
BU
2021QUANTERIX CORPORATION : to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
BU
2021QUANTERIX : Appoints Michael Doyle as Chief Financial Officer Doyle brings strong financia..
PU
2021QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
2021QUANTERIX : Appoints Michael Doyle as Chief Financial Officer
BU
2021QUANTERIX CORP : Submission of Matters to a Vote of Security Holders, Financial Statements..
AQ
2021QUANTERIX : rsquo; Simoa Technology Powers Largest and Most Diverse Global Investigation o..
PU
2021QUANTERIX : rsquo; Simoa Technology Powers Largest and Most Diverse Global Investigation o..
BU
2021QUANTERIX : Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42 Annual Glo..
PU
2021QUANTERIX : Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual G..
BU
2021QUANTERIX : Toloue brings deep expertise and industry acumen to lead the Company's strateg..
PU
2021QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
2021QUANTERIX : Appoints Masoud Toloue as President of Quanterix and Diagnostics
BU
2021QUANTERIX : Q1 GAAP revenue including grant revenue $27.2M; Q1 non-GAAP revenue $24.9M, an..
PU
2021QUANTERIX : Management's Discussion and Analysis of Financial Condition and Results of Ope..
AQ
2021QUANTERIX : Q1 2021 Earnings Call
PU
2021QUANTERIX CORPORATION : Releases Operating Results for First Quarter 2021
BU
2021QUANTERIX CORPORATION : to Release First Quarter 2021 Financial Results on May 5, 2021
BU
2021QUANTERIX : Pharmaceutical veteran adds deep expertise in commercial and corporate strateg..
PU
2021QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
2021QUANTERIX : Appoints Laurie Olson to Board of Directors
BU
2021QUANTERIX WEBINAR : Recent Advancements in Neurodegenerative Biomarkers: Progress Towards ..
BU
2021QUANTERIX CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021QUANTERIX : Announces Appointment of Interim Chief Financial Officer
BU
2021QUANTERIX CORP : Change in Directors or Principal Officers (form 8-K)
AQ
2021QUANTERIX CORP : Change in Directors or Principal Officers (form 8-K)
AQ
1  2  3Volgende
Volgende evenement op QUANTERIX CORPORATION